Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-31
2005-05-31
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S561000
Reexamination Certificate
active
06900200
ABSTRACT:
This invention provides novel substituted tricyclic carboxamides which act as oxytocin receptor competitive antagonists, as well as methods of their manufacture, pharmaceutical compositions and methods of their use in treatment, inhibition, suppression or prevention of preterm labor, dysmenorrhea and endometritis, suppression of labor at term prior to caesarean delivery, and to facilitate antinatal transport to a medical facility. These compounds are also useful in enhancing fertility rates, enhancing survival rates and synchronizing estrus in farm animals; and may be useful in the prevention and treatment of disfunctions of the oxytocin system in the central nervous system including obsessive compulsive disorder (OCD) and neuropsychiatric disorders.
REFERENCES:
patent: 4766108 (1988-08-01), Ali
patent: 5055448 (1991-10-01), Manning et al.
patent: 5070187 (1991-12-01), Gavras et al.
patent: 5258510 (1993-11-01), Ogawa et al.
patent: 5436333 (1995-07-01), Venkatesan et al.
patent: 5459131 (1995-10-01), Albright et al.
patent: 5466584 (1995-11-01), Tanizawa et al.
patent: 5512563 (1996-04-01), Albright et al.
patent: 5516774 (1996-05-01), Albright et al.
patent: 5521173 (1996-05-01), Venkatesan et al.
patent: 5532235 (1996-07-01), Albright et al.
patent: 5536718 (1996-07-01), Albright et al.
patent: 5609851 (1997-03-01), Bennani
patent: 5654297 (1997-08-01), Albright et al.
patent: 5665719 (1997-09-01), Bock et al.
patent: 5670509 (1997-09-01), Evans et al.
patent: 5726172 (1998-03-01), Sparks et al.
patent: 5736540 (1998-04-01), Albright et al.
patent: 5753644 (1998-05-01), Ogawa et al.
patent: 5756497 (1998-05-01), Bell et al.
patent: 5756504 (1998-05-01), Bock et al.
patent: 5780471 (1998-07-01), Venkatesan et al.
patent: 5849735 (1998-12-01), Albright et al.
patent: 5880122 (1999-03-01), Trybulski et al.
patent: 5968930 (1999-10-01), Albright et al.
patent: 6268359 (2001-07-01), Ogawa et al.
patent: 6340678 (2002-01-01), Matsuhisa et al.
patent: 2002/0183311 (2002-12-01), Failli et al.
patent: 2002/0198196 (2002-12-01), Failli et al.
patent: 2003/0004159 (2003-01-01), Failli et al.
patent: 2003/0008863 (2003-01-01), Failli et al.
patent: 2003/0027815 (2003-02-01), Failli et al.
patent: 2003/0055046 (2003-03-01), Failli et al.
patent: 2003/0055047 (2003-03-01), Failli et al.
patent: 0 382 185 (1990-08-01), None
patent: 0 470 514 (1992-02-01), None
patent: 0 514 667 (1992-11-01), None
patent: 0 533 240 (1993-03-01), None
patent: 0 533 242 (1993-03-01), None
patent: 0 533 243 (1993-03-01), None
patent: 0 533 244 (1993-03-01), None
patent: 0 620 216 (1994-10-01), None
patent: 2 326 410 (1998-12-01), None
patent: 2 326 639 (1998-12-01), None
patent: WO 91/05549 (1991-05-01), None
patent: WO 94/01113 (1994-01-01), None
patent: WO 94/04525 (1994-03-01), None
patent: WO 94/12476 (1994-06-01), None
patent: WO 94/14796 (1994-07-01), None
patent: WO 94/20473 (1994-09-01), None
patent: WO 96/09824 (1996-04-01), None
patent: WO 96/22282 (1996-07-01), None
patent: WO 96/22292 (1996-07-01), None
patent: WO 96/22294 (1996-07-01), None
patent: WO 96/22775 (1996-08-01), None
patent: WO 97/25992 (1997-07-01), None
patent: WO 98/20011 (1998-05-01), None
patent: 98/20011 (1998-05-01), None
patent: 0 636 625 (1999-01-01), None
patent: WO 99/06409 (1999-02-01), None
patent: WO 99/24051 (1999-05-01), None
Wolff, Manfred E. “Burger's Medicinal Chemistry, 5ed, Part I”, John Wiley & Sons, 1995, pp. 975-977.*
Banker, G.S. et al, “Modern Pharmaceutics, 3ed.”, Marcel Dekker, New York, 1996, p. 596.*
PubMed Abstract 12848639, also cited as Acta Obstet Gynecol, 2003, 82(8), 687-704.
PubMed Abstract 12436949, also cited as Prog Brain Res, 2002, 139, 359-65.
PubMed Abstract 9891619, also cited as Clin Perinatol, 1998, 25(4), 859-71.
Mats Akerlund, Acta Obstet. Gynecol. Scand., 1987, 459-461, 66.
Mats Akerlund, Reg. Pept., 1993, 187-191, 45.
Ian M. Bell et al., J. Med. Chem., 1998, 2146-2163, 41.
Ya Li Chen et al., Eur. J. Pharmacol., 1999, 25-51, 376.
J.J. Evans et al., J. Endocrinol., 1989, 107-116, 122.
Ben E. Evans et al., J. Med. Chem., 1993, 3993-4006, 36.
Ben E. Evans et al., J. Med. Chem., 1992, 3919-3927, 35.
Anna-Riitta Fuchs et al., Science, 1982, 1396-1398, 215.
Andre Giroux et al., Tetr. Lett., 1997, 3841-3844, 38.
T. Murphy Goodwin et al., Obstet. Gynecol., 1996, 331-336, 88.
Aleksandar Jovanovic et al., Br. J. Pharmacol., 1997, 1468-1474, 12.
Mario Maggi et al., J. Clin. Endocrinol. Metab., 1990, 1142-1154, 70.
A. Okano, J. Reprod. Dev., 1996, 67-70, 42 (Suppl.).
D.J. Pettibone et al., Biochem. Soc. Trans., 1997, 1051-1057, 25(3).
V. Rettori et al., Proc. Nat. Acad. Sci. U.S.A., 1997, 2741-2744, 94.
G. Robinson et al., J. Endocrinol., 1990, 425-432, 125.
Olga Wellnitz et al., J. Dairy Res., 1999, 1-8, 66.
Gabor L. Kovacs et al., Psychoneuroendocrinology, 1998, 945-962, 23(8).
Margaret M. McCarthy et al., Molecular Medicine Today, 1997, 269-275, 3(6).
James. F. Leckman et al., Psychoeuroendocrinology, 1994, 723-749, 19(8).
Caggiano Thomas Joseph
Failli Amedeo Arturo
Memoli Kevin Anthony
Sabatucci Joseph P.
Sanders William Jennings
Berch Mark L
McKenzie Thomas
Woodcock & Washburn LLP
Wyeth
LandOfFree
Tricyclic hydroxy carboxamides and derivatives thereof... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic hydroxy carboxamides and derivatives thereof..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic hydroxy carboxamides and derivatives thereof... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3417396